GlassScriptPhysician profile
Victoria K Young
NPI 1275554941
$552.45
in general payments reported to CMS, 2019-2025
16 companies · $62.34 in 2025
The $62.34 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $69.54 · 2024: $155 · 2025: $62.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $121.82 | 2024 | Menopur |
| Boston Scientific Corporation | $62.34 | 2025 | Wavewriter Alpha Prime 16 |
| Merck Sharp & Dohme LLC | $58.02 | 2019 | |
| Abbvie INC. | $45.90 | 2019-2020 | |
| Roche Diagnostics Corporation | $44.53 | 2019-2020 | |
| Coopersurgical, INC. | $32.99 | 2019 | |
| Hologic Sales and Service, LLC | $32.74 | 2024 | Aptima |
| Avion Pharmaceuticals | $23.72 | 2020 | |
| Therapeuticsmd, INC. | $18.76 | 2019 | |
| Pfizer INC. | $17.98 | 2019 | |
| Lupin INC. | $17.72 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.02 | 2019 | |
| Duchesnay USA Incorporated | $15.88 | 2019 | |
| Ethicon US, LLC | $15.77 | 2019 | |
| Astellas Pharma US INC | $14.35 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.